Skip to main content

Find Clinical Trials

Home
Conditions
Liver Cirrhosis

Clinical trial condition

Liver Cirrhosis

Explore clinical trials studying Liver Cirrhosis. Study availability and eligibility vary by location and protocol.

818 public trials 165 recruiting studies

Refine in advanced search Browse all conditions

Liver Cirrhosis trial results

Completed

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

NCT01006031

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +23 more
Locations: Hospital Universitario Reina Sofía Córdoba, Spain

Hospitales Universitarios Virgen del Rocío Seviila, Spain

Hospital Universitario de Valme Seville, Spain

Hospital Universitario Virgen Macarena Seville, Spain

View Trial Details

Completed

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease

NCT01355107

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +21 more
Locations: University Medical Center Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany

View Trial Details

Completed

Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed

NCT00689754

Conditions: Digestive System Diseases, Fibrosis, Gastrointestinal Diseases, +6 more
Locations: Parkland Memorial Hospital Dallas, Texas, United States

View Trial Details

Completed

Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis

NCT01342250

Conditions: Digestive System Diseases, Fibrosis, Liver Cirrhosis, +3 more
Locations: Shanghai Liver Disease Research Center, the Nanjing Military Command (Shanghai 85 Hospital) Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

NCT00469131

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations: Kyoto University Hospital Kyoto, Japan

View Trial Details

Completed

Non-invasive Assessment of Liver Stiffness/Fibrosis by Transient Elastography (Fibroscan) in Patients With Left and/or Right Sided Heart Failure

NCT00777725

Conditions: Cardiovascular Diseases, Digestive System Diseases, Fibrosis, +7 more
Locations: Alfred Hospital Melbourne, Victoria, Australia

View Trial Details

Completed

Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

NCT01359462

Conditions: Ascites, Digestive System Diseases, Fibrosis, +5 more
Locations: Renji Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor

NCT00941902

Conditions: Digestive System Diseases, Fibrosis, Liver Cirrhosis, +4 more
Locations: ZIV Medical Center Safed, Israel

View Trial Details

Completed

Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)

NCT00885313

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +19 more
Locations: Bambino Gesù Hospital and Research Institute Rome, Italy

View Trial Details

Completed

Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

NCT00926224

Conditions: Cirrhosis, Digestive System Diseases, Fibrosis, +5 more
Locations: Calgary University Hospital Calgary, Alberta, Canada

London University Hospital London, Ontario, Canada

Toronto Western General Hospital Toronto, Ontario, Canada

Toronto Liver Centre Toronto, Ontario, Canada

View Trial Details